Clinical Trial

Access to Probing and Peri-implant Diseases

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter cross-sectional study aims to evaluate the association between access to peri-implant probing and radiographic peri-implant bone loss. Although probing is the primary diagnostic tool for peri-implant diseases, prosthetic design may limit access, potentially affecting diagnosis and disease progression. The study will include patients with dental implants in function for at least three years and will assess clinical, radiographic, and prosthetic variables.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-23.
Trial Details
NCT Number NCT07557459
Lead Sponsor Arrow Development
Collaborators: Salud y Estetica Dental SCH Zurbano S.L, Clinica Dental Nexus, Malaga, Clinica Bio, Madrid, Centro de Periodoncia e Implantes Aranda-Macera, Madrid, Clínica Sánchez Cortés, Madrid, Madrid Perio & Implant Clinic, Madrid, Clínica Barbieri, A Coruña, Clinica Ortiz-Vigon, Bilbao, PerioCentrum Guadalajara
Conditions Peri-implantitis, Peri-implant Bone Loss
Enrollment 281 participants
Start Date 2026-05
Primary Completion 2027-05 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-12